Fda Backs Pfizer Covid-19 Boosters For Seniors, High-risk

The Associated Press, Bangor Daily News
Wed, 09/22/2021 - 4:54pm

The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of the extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19.

NEXT
Sections:  u.s.   
Topics:  Maine   Penobscot County   Bangor   
BING NEWS:
  • COVID-19 booster immunity lasts much longer than primary series alone, study shows
    A new study shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other, sometimes 'unintuitive,' revelations of how factors like age, ...
    04/29/2024 - 10:35 am | View Link
  • FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
    The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The ...
    04/26/2024 - 7:55 am | View Link
  • FDA review confirms safety and efficacy of Pfizer coronavirus vaccine
    Updated Dec. 8 at 1:30 p.m. Pfizer enrolled approximately 44,000 ... So far, there have been 170 cases of covid-19, the illness caused by the coronavirus, in people who were not previously infected.
    12/8/2020 - 12:30 am | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More U.s. News